FibroNox
PrivateLast Round
Grant
Jun 1, 2024
Total Funding Raised
$2.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FibroNox is a biotechnology company that develops selective Nox4 inhibitors and Nrf2 activators to treat fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FibroNox Comparables
Compare FibroNox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glucox Biotech AB | 78% | |
| Asahi Kasei | 73% | |
| Tvardi | 73% | |
FibroNox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2024 | ||||
| Grant | May 15, 2024 | ||||
| Grant | Sep 15, 2020 | ||||
| Accelerator | Feb 26, 2019 |
FibroNox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Monthly visitors grew 484% MoM, reaching 1K.
- Jun 1, 2024
$2M grant from National Heart, Lung, and Blood Institute and NIH.
FibroNox Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FibroNox's valuation, stock price, and market status.